Liege, Belgium, 29 March 2022 – 18:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency from François Fornieri, on 24 March 2022. M. Fornieri has notified Mithra that it has dropped below the legal 25% threshold on 21, March 2022.

Liege, Belgium, 29 March 2022 –17:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency from Goldman Sachs Group, Inc., with registered offices at Corporation Trust Center, 1209 Orange Street, Wilmington, DE 19801, USA, on 28, March 2022. Goldman Sachs has notified Mithra that it has exceeded the legal 3% threshold on 22, March 2022.

Liege, Belgium, 23 March 2022 –17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency from Goldman Sachs Group, Inc., with registered offices at Corporation Trust Center, 1209 Orange Street, Wilmington, DE 19801, USA, on 18 March 2022. Goldman Sachs has notified Mithra that it has fallen below the legal 3% threshold on 14 March 2022.

 

Liege, Belgium, 21 March 2022 – 17:45 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA)
(the “Company” or “Mithra”), a company dedicated to Women’s Health, today announces that it has exercised a second drawing request for an amount of EUR 5 million, according to the terms of the equity funding agreement signed with Goldman Sachs International (“GSI”) on February 4, 2022.

Further to Mithra’s first drawing requestexercised on 4 February 2022, GSI has elected to exercise a call option for an amount of EUR 5 million. This call option will result in the issuance of 377,198 shares of the Company.

In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, following this capital increase’s completion Mithra now has 44,870,648 outstanding shares carrying voting rights (against 44,493,450 outstanding shares carrying voting rights previously).

Liege, Belgium, 08 March 2022 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces its financial results for the year ended 31 December 2021, prepared in accordance with IFRS.